Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Martin Julian Abrahamson, M.B.,CH.B.

TitleAssociate Professor of Medicine
InstitutionJoslin Diabetes Center
DepartmentMedicine
AddressJoslin Diabetes Center
Room 267
One Joslin Place
Boston MA 02215
Phone617/732-2402
Fax617/713-3417

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Mehta SN, Goldfine AB, Abrahamson MJ, Divincenzo R, Laffel LM. Changing prescribing patterns of type 2 diabetes medications from 2002-2010: an electronic health record-based evaluation. J Diabetes Sci Technol. 2013; 7(1):119-22.
    View in: PubMed
  2. Beverly EA, Brooks KM, Ritholz MD, Abrahamson MJ, Weinger K. Assessment of emotional struggles in type 2 diabetes: patient perspectives. Diabetes Care. 2012 Aug; 35(8):e62.
    View in: PubMed
  3. Abrahamson MJ, Peters A. Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy. Ann Med. 2012 Dec; 44(8):836-46.
    View in: PubMed
  4. Beverly EA, Ritholz MD, Brooks KM, Hultgren BA, Lee Y, Abrahamson MJ, Weinger K. A qualitative study of perceived responsibility and self-blame in type 2 diabetes: reflections of physicians and patients. J Gen Intern Med. 2012 Sep; 27(9):1180-7.
    View in: PubMed
  5. Ganda OP, Jumes CG, Abrahamson MJ, Molla M. Quantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in patients with diabetes and hypertriglyceridemia. Diabetes Res Clin Pract. 2012 Jul; 97(1):51-6.
    View in: PubMed
  6. Ritholz MD, Beverly EA, Abrahamson MJ, Brooks KM, Hultgren BA, Weinger K. Physicians' perceptions of the type 2 diabetes multi-disciplinary treatment team: a qualitative study. Diabetes Educ. 2011 Nov-Dec; 37(6):794-800.
    View in: PubMed
  7. Beverly EA, Hultgren BA, Brooks KM, Ritholz MD, Abrahamson MJ, Weinger K. Understanding physicians' challenges when treating type 2 diabetic patients' social and emotional difficulties: a qualitative study. Diabetes Care. 2011 May; 34(5):1086-8.
    View in: PubMed
  8. Meneghini L, Liebl A, Abrahamson MJ. Insulin detemir: A historical perspective on a modern basal insulin analogue. Prim Care Diabetes. 2010 Apr; 4 Suppl 1:S31-42.
    View in: PubMed
  9. Abrahamson MJ. Basal insulins: Pharmacological properties and patient perspectives. Prim Care Diabetes. 2010 Apr; 4 Suppl 1:S19-23.
    View in: PubMed
  10. Dushay J, Abrahamson MJ. Insulin therapy for type 2 diabetes: making it work. J Fam Pract. 2010 Apr; 59(4):E1-8.
    View in: PubMed
  11. Kumar R, Lee TT, Jeremias A, Ruisi CP, Sylvia B, Magallon J, Kirtane AJ, Bigelow B, Abrahamson M, Pinto DS, Ho KK, Cohen DJ, Carrozza JP, Cutlip DE. Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients. Am J Cardiol. 2007 Oct 15; 100(8):1187-91.
    View in: PubMed
  12. Abrahamson MJ. A 74-year-old woman with diabetes. JAMA. 2007 Jan 10; 297(2):196-204.
    View in: PubMed
  13. Ashkenazy R, Abrahamson MJ. Medicare coverage for patients with diabetes. A national plan with individual consequences. J Gen Intern Med. 2006 Apr; 21(4):386-92.
    View in: PubMed
  14. Mehta SS, Silver RJ, Aaronson A, Abrahamson M, Goldfine AB. Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus. Am J Cardiol. 2006 Feb 15; 97(4):567-70.
    View in: PubMed
  15. Drexler AJ, Nesto RW, Abrahamson MJ, Bakris G, Bell D, Brunzell J, Dandona P, Davidson J, Fonseca V, Fowler M, Frye R, Giles T, Haffner S, Hollenberg N, Hsueh W, Law R, Plutzky J, Ratner R, Reusch J, Selwyn A, Sowers J, Wyne K, Young LH. Evaluating the cardiovascular effects of the thiazolidinediones and their place in the management of type 2 diabetes in relation to the metabolic syndrome. Metab Syndr Relat Disord. 2005; 3(2):147-73.
    View in: PubMed
  16. Geller SE, Abrahamson MJ. Toward optimal health: the experts discuss important issues in hormone replacement and in diabetes. Interview by Jody R. Godfrey. J Womens Health (Larchmt). 2004 Dec; 13(10):1075-9.
    View in: PubMed
  17. Gaglia JL, Wyckoff J, Abrahamson MJ. Acute hyperglycemic crisis in the elderly. Med Clin North Am. 2004 Jul; 88(4):1063-84, xii.
    View in: PubMed
  18. Serdy S, Abrahamson MJ. Durability of glycemic control: a feature of the thiazolidinediones. Diabetes Technol Ther. 2004 Apr; 6(2):179-89.
    View in: PubMed
  19. Abrahamson MJ. Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context. Arch Intern Med. 2004 Mar 8; 164(5):486-91.
    View in: PubMed
  20. Abrahamson MJ. Clinical use of thiazolidinediones: recommendations. Am J Med. 2003 Dec 8; 115 Suppl 8A:116S-120S.
    View in: PubMed
  21. Chan JL, Abrahamson MJ. Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin. Mayo Clin Proc. 2003 Apr; 78(4):459-67.
    View in: PubMed
  22. Mulligan GP, Davidson JS, Kaplan H, Abrahamson MJ. Euthyroid hyperthyroxinaemia due to endogenous antibodies to thyroxine and tri-iodothyronine. A case report. S Afr Med J. 1989 Feb 18; 75(4):181-3.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Abrahamson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_